Biblio

Gross-Goupil M, Flechon A, Chevreau C, Topart D, Gravis G, Oudard S, Tourani J-M, Geoffrois L, Meriaux E, Thiery-Vuillemin A et al..  2020.  Real-world data of cabozantinib in patients with VEGF-refractory metastatic renal cell carcinoma (mRCC): Results from the French Early Access Program (CABOREAL). JOURNAL OF CLINICAL ONCOLOGY. 38

Halmos B, Tan E-H, Lee MKi, Foucher P, Hsia T-C, Hochmair MJ, Griesinger F, Hida T, Kim ES, Melosky BL et al..  2018.  Real-world dose adjustment study of first-line afatinib in pts with EGFR mutation-positive (EGFRm plus ) advanced NSCLC.. JOURNAL OF CLINICAL ONCOLOGY. 36

Casarotto E, Chandwani S, Mortier L, Dereure O, Dutriaux C, Dalac S, Scherrer E, Levy-Bachelot L, Verdoni L, Farge G et al..  2021.  Real-world effectiveness of pembrolizumab in advanced melanoma: analysis of a French national clinicobiological database. IMMUNOTHERAPY. 13:905-916.

Kodjikian L, Baillif S, Creuzot-Garcher C, Delyfer M-N, Matonti F, Weber M, Mathis T.  2021.  Real-World Efficacy and Safety of Fluocinolone Acetonide Implant for Diabetic Macular Edema: A Systematic Review. PHARMACEUTICS. 13:72.

Heudel P, Delaloge S, Parent D, Madranges N, Levy C, Dalenc F, Brain E, Uwer L, D'Hondt V, Augereau P et al..  2020.  Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC Study. ANTICANCER RESEARCH. 40:3905-3913.

Perol M., Filleron T., Quantin X., Chouaid C., C. Valette A, Lena H., Kaderbhai C., Fabre C., Santorelli M., Bensimon L. et al..  2021.  Real-world evaluation of pembrolizumab monotherapy for PD-L1 positive (TPS > 50%) metastatic NSCLC in France. JOURNAL OF THORACIC ONCOLOGY. 16:S757-S758.

Perol M., Quantin X., Lena H., Filleron T., Chouaid C., C. Valette A, Kaderbhai C., Chenuc G., Santorelli M., Bensimon L. et al..  2021.  Real-world evaluation of pembrolizumab monotherapy for previously treated PD-L1 positive (TPS > 1%) advanced NSCLC in France. JOURNAL OF THORACIC ONCOLOGY. 16:S758.

Albiges L, Flechon A, Chevreau C, Topart D, Gravis G, Oudard S, Tourani JM, Geoffrois L, Meriaux E, Thiery-Vuillemin A et al..  2021.  Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program. EUROPEAN JOURNAL OF CANCER. 142:102-111.

Ysebaert L, Michallet A-S, Bijou F, Clavert A, Quinquenel A, Calleja A, Guieze R, Ferrant E, Brion A, Laribi K.  2019.  Real-World Ibrutinib Validation of the Ball Score to Predict Overall Survival: A Filo Group Study in RR CLL Patients. BLOOD. 134

Busch C, Fraser-Bell S, Iglicki M, Lupidi M, Couturier A, Chaikitmongkol V, Giancipoli E, Rodriguez-Valdes PJ, Gabrielle P-H, Lains I et al..  2019.  Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results. ACTA DIABETOLOGICA. 56:1341-1350.

Busch C, Fraser-Bell S, Zur D, Rodriguez-Valdes PJ, Cebeci Z, Lupidi M, Fung AT, Gabrielle P-H, Giancipoli E, Chaikitmongkol V et al..  2019.  Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study. ACTA DIABETOLOGICA. 56:777-784.

Massin P, Creuzot-Garcher C, Kodjikian L, Girmens J-F, Delcourt C, Fajnkuchen F, Glacet-Bernard A, Guillausseau P-J, Ponthieux A, Blin P et al..  2019.  Real-World Outcomes with Ranibizumab 0.5 mg in Patients with Visual Impairment due to Diabetic Macular Edema: 12-Month Results from the 36-Month BOREAL-DME Study. OPHTHALMIC RESEARCH. 62:101-110.

Garcher CPCreuzot, Massin P, Kodjikian L, Girmens J-F, Delcourt C, Fajnkuchen F, Glacet A, Guillausseau P-J, Derveloy A, Finzi L et al..  2017.  Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to diabetic macular edema: 12-month results from the 36-month BOREAL-DME study. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 58

Srour M, Glacet A, Girmens J-F, Kodjikian L, Delcourt C, Fajnkuchen F, Garcher CPCreuzot, Massin P, Guillausseau P-J, Ponthieux A et al..  2017.  Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to macular edema secondary to central retinal vein occlusion: 6-month results from the 24-month BOREAL-CRVO study. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 58

Garcher CPCreuzot, Massin P, Kodjikian L, Girmens J-F, Delcourt C, Fajnkuchen F, Glacet A, Guillausseau P-J, Derveloy A, Finzi L et al..  2017.  Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to diabetic macular edema: 12-month results from the 36-month BOREAL-DME study. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 58

Pearce I, Clemens A, Brent MH, Lu L, Gallego-Pinazo R, Minnelle AMaria, Creuzot-Garcher C, Spital G, Sakamoto T, Dunger-Baldauf C et al..  2020.  Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS study. PLOS ONE. 15:e0234739.

Girard N., Perol M., Simon G., C. Valette A, Gervais R., Debieuvre D., Schott R., Quantin X., Coudert B., Lena H. et al..  2019.  Real-world treatment patterns, clinical practice and outcomes for locally advanced, non resectable, non-small cell lung cancer from the French ESME Lung database. ANNALS OF ONCOLOGY. 30

Costanzo V, Zarba J., Michelotti A., Livi L., Villanueva C., Bordonaro R., Sherstnev V, Kowalyszyn R., Marinsek N., Zhou Z. et al..  2016.  REAL-WORLD TREATMENT PATTERNS OF EVEROLIMUS plus EXEMESTANE IN PATIENTS WITH HORMONE-RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-NEGATIVE ADVANCED BREAST CANCER BY LINE OF THERAPY: A GLOBAL CHART REVIEW. VALUE IN HEALTH. 19:A136.

Jattiot R, Lehmann J, Latutrie B, Vuarin P, Tajika A, Vennin E.  2021.  Reappraisal of the latest Albian (Mortoniceras fallax Zone) cephalopod fauna from the classical Salazac locality (Gard, southeastern France). GEOBIOS. 64:1-46.

Normand AT, E. Carrizo DSosa, Magnoux C, Lobato E, Cattey H, Richard P, Brandes S, Devillers CH, Romieu A, Le Gendre P et al..  2021.  Reappraising Schmidpeter's bis(iminophosphoranyl)phosphides: coordination to transition metals and bonding analysis. CHEMICAL SCIENCE. 12:253-269.

Muzammel M, Yusoff MZuki, Meriaudeau F.  2017.  Rear-end vision-based collision detection system for motorcyclists. JOURNAL OF ELECTRONIC IMAGING. 26:033002.

Arenas H, Harbelot B, Cruz C.  2015.  Reasoning with Vague Spatial Information from Upper Mesopotamia (2000BC). SPATIAL STATISTICS CONFERENCE 2015, PART 2. 27:58-65.

Balkau B, Halimi S, Blickle J-F, Verges B, Avignon A, Attali C, Chartier I, Amelineau E.  2016.  Reasons for non-intensification of treatment in people with type 2 diabetes receiving oral monotherapy: Outcomes from the prospective DIAttitude study. ANNALES D ENDOCRINOLOGIE. 77:649-657.

Yatskul A, Lemiere J-P.  2017.  Reasons of irregularity of seed's distribution in the divider heads of air-seeders. LAND, TECHNIK AGENG 2017: THE FORUM FOR AGRICULTURAL ENGINEERING INNOVATIONS (VDI-MEG 2017). 2300:337-344.

Yatskul A, Lemiere J-P.  2017.  Reasons of irregularity of seed's distribution in the divider heads of air-seeders. LAND, TECHNIK AGENG 2017: THE FORUM FOR AGRICULTURAL ENGINEERING INNOVATIONS (VDI-MEG 2017). 2300:337-344.